With a Bachelor’s in biotechnology from PXL University and a Master’s in Biomedical sciences from Hasselt University, Jonas started his PhD in Oktober 2024 under the supervision of Dr. Sabine van Rijt. His project is focusses on the development of a versatile nanoparticle platform designed to bind proteins, enhancing their stability and bioactivity while retaining their native configuration. By leveraging silica nanoparticles with an innovative linker, this platform offers a simple, controlled, and stable environment for protein attachment, ensuring that the proteins maintain their structural integrity and function.

The primary goal of this research is to drive key biological processes such as angiogenesis and bone regeneration. The platform is designed to not only support the proteins' natural configuration but also amplify their therapeutic potential, ultimately paving the way for advanced biomaterials. The project seeks to contribute to the development of cutting-edge technologies in the field of regenerative medicine, offering new opportunities for effective treatments.